Get the Stockscreener App
6.20
9.62%
-0.66
After Hours:
6.39
0.19
+3.06%
Mei Pharma Inc stock is traded at $6.20, with a volume of 424.83K.
It is down -9.62% in the last 24 hours and up +181.82% over the past month.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
See More
Previous Close:
$6.86
Open:
$6.3
24h Volume:
424.83K
Relative Volume:
0.52
Market Cap:
$41.31M
Revenue:
$105.38M
Net Income/Loss:
$17.78M
P/E Ratio:
2.3221
EPS:
2.67
Net Cash Flow:
$-50.48M
1W Performance:
+60.62%
1M Performance:
+181.82%
6M Performance:
+119.86%
1Y Performance:
+69.86%
1-Day Range:
$6.20
$6.5199
1-Week Range:
$3.65
$9.00
52-Week Range:
$1.46
$9.00
Mei Pharma Inc Stock (MEIP) Company Profile
Name
Mei Pharma Inc
Sector
Industry
Phone
858-369-7100
Address
11455 EL CAMINO REAL, SAN DIEGO, CA
Compare MEIP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEIP
Mei Pharma Inc
|
6.20 | 45.71M | 105.38M | 17.78M | -50.48M | 2.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Downgrade | Laidlaw | Buy → Hold |
| Mar-25-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-25-22 | Downgrade | Stifel | Buy → Hold |
| Mar-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-03-22 | Initiated | Jefferies | Buy |
| Sep-22-20 | Initiated | Alliance Global Partners | Buy |
| May-29-20 | Initiated | SunTrust | Buy |
| Dec-20-18 | Initiated | H.C. Wainwright | Buy |
| Jul-27-18 | Upgrade | Stifel | Hold → Buy |
| Jul-13-18 | Initiated | SunTrust | Buy |
| Apr-18-16 | Reiterated | Wedbush | Neutral |
| Mar-23-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Dec-18-14 | Reiterated | ROTH Capital | Buy |
| Oct-16-14 | Reiterated | ROTH Capital | Buy |
| Jul-08-14 | Resumed | Brean Capital | Buy |
| Oct-22-13 | Reiterated | Stifel | Buy |
| Apr-15-13 | Initiated | Stifel | Buy |
View All
Mei Pharma Inc Stock (MEIP) Latest News
Now Litecoin? Pharmaceuticals Firm Closes Deal to Fund $100M LTC Treasury - Decrypt
What analysts say about MEI Pharma Inc. stockConsistently high returns - Autocar Professional
Mei Pharma Plunges 9.04% Amid Litecoin Reserve Shift - AInvest
MEI Pharma's $100M Litecoin Investment Sparks 111% Stock Surge, Second $100M Raise in Works - AInvest
MEI Pharma Allocates $100M to Litecoin as Strategic Reserve Share Price Surges 172.6% After Announcement - AInvest
MEI Pharma soars after $100M litecoin treasury move, first public LTC holder on U.S. exchange - MSN
MEI Pharma Inc. Stock Analysis and ForecastFree Stock Movement Tracking - jammulinksnews.com
MEI Pharma's $100M Shift to Litecoin Treasury: A Bold Move or a Strategic Bet on Digital Assets? - AInvest
What drives MEI Pharma Inc. stock priceAccelerated financial growth - jammulinksnews.com
MEI Pharma Raises $100M to Buy Litecoin, First Public Company to Hold LTC as Treasury Asset - CTOL Digital Solutions
MEI Pharma’s Strategic Shift with Litecoin Treasury - TipRanks
MEI Pharma closes $100 million placement to adopt Litecoin treasury strategy - Investing.com
MEI Pharma adopts Litecoin as treasury reserve in $100 million deal - Investing.com
MEI Pharma Allocates $100M to Litecoin, Becoming First US-Listed Company with Cryptocurrency as Primary Reserve; Coin Surges to Multi-Year High - AInvest
MEI Pharma closes $100 million placement to adopt Litecoin treasury strategy By Investing.com - Investing.com South Africa
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
Is MEI Pharma Inc. a good long term investmentSuperior portfolio returns - jammulinksnews.com
MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange - MSN
MEI Pharma Trades Cash For LTC - Asianet Newsable
Stocks in play: Enthusiast Gaming Holdings Inc. - The Globe and Mail
Will MEI Pharma Inc. stock benefit from AI tech trendsHigh Confidence Trade Setups - Newser
MEI Pharma Inc (MEIP) Stock: Navigating a Year of Volatility - investchronicle.com
Why MEI Pharma Inc. stock attracts strong analyst attentionReal Time Stock Signal - Newser
How MEI Pharma Inc. stock performs during market volatilityStable Stocks With High Yield - Newser
MEI Pharma bets 100 million yuan on Litecoin, is the altcoin micro-strategy craze coming?-web3资讯 - ODAILY
LTC Hits Wall Street Stage: MEI Pharma's 'Litecoin Treasury' Surges Over 80% - Binance
LTC takes the stage on Wall Street: MEI Pharma's "Litecoin Vault" rises over 80%. - 富途牛牛
Bitcoin News Today: MEI Pharma Invests $100 Million in Litecoin Treasury - AInvest
Why Litecoin Soared Over the Weekend - Yahoo Finance
MEIP's Volatile Surge: A 25% Intraday Rally Sparks Market Buzz - AInvest
MEI Pharma Shares Surge After Unveiling $100 Million Litecoin Treasury Plan - MSN
MEI Pharma Invests $100 Million in Litecoin, Stock Jumps 83% - AInvest
MEI Pharma Secures $100M Investment, Acquires Litecoin, and Appoints Charlie Lee to Board. - AInvest
MEI Pharma's Pioneering Litecoin Treasury Strategy: A New Frontier in Biotech Capital Management - AInvest
MEI Pharma's Litecoin Treasury Strategy: A Game-Changer in Biotech Finance and Institutional Crypto Adoption - AInvest
GSR leads $100M private placement into MEI Pharma to launch Litecoin treasury - MSN
MEI Pharma announces $100M PIPE deal to add Litecoin to corporate treasury - MSN
MEI Pharma Launches Litecoin Treasury Strategy With $100M Private Placement - namecoinnews.com
GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee - Chainwire
GSR Invests $100M in MEI Pharma to Launch First Institutional Litecoin Treasury with Charlie Lee - ZyCrypto
Why LTC is up today (July 18)? - Traders Union
MEI Pharma Invests $100 Million in Litecoin for Treasury Reserve - AInvest
MEI Pharma Unveils $100M Litecoin Treasury, Becomes First Public Firm To Hold LTC As Reserve - StartupNews.fyi
Why Is MEI Pharma Stock Soaring On Friday? - Benzinga
Bitcoin News Today: MEI Pharma Commits $100 Million to Litecoin Treasury Strategy - AInvest
MEI Pharma (NASDAQ; MEIP) Unveils $100 million Treasury Strategy for Litecoin - FXDailyReport.Com
MEI Pharma Adopts $100M Litecoin Treasury Strategy - AInvest
MEI Pharma Commits $100M to Litecoin Treasury Strategy: Can LTC Price 10x? - Blockonomi
Syed92110 - Binance
MEI Pharma (MEIP) Stock: Soars 33% After $100M Litecoin Treasury Pivot - CoinCentral
Can Litecoin price rally reach $140 in July after $100 million LTC treasury unveiling? - FXStreet
Mei Pharma Inc Stock (MEIP) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.91%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):